Media Centre - IARC NEWS


Vacancy, Director, IARC
Applications from highly qualified persons are invited for the post of Director, IARC. The appointment of the Director will be made in May 2018 for a term of five years beginning on 1 January 2019. The selected candidate may be eligible for one further five-year term.

The deadline for the receipt of applications is the closure of working hours on 15 February 2018.

Download application form
Métropole de Lyon and IARC unveil plans for new IARC building
After an 18-month international competitive bidding process for the design and construction of the “Nouveau Centre” (combined design-build contract) for the International Agency for Research on Cancer (IARC), the winning team has been selected by the Métropole de Lyon. The team consists of Demathieu Bard (general contractor), Art&Build (architects), Unanime (architects), WSP (design engineering company), and Inddigo (sustainable development engineering company). The project is managed by the Métropole de Lyon and funded by the French government, the Métropole de Lyon, the Région Auvergne-Rhône-Alpes, and the Ville de Lyon.

More information
IARC Postdoctoral Opportunities – Section of Nutrition and Metabolism/Nutritional Methodology and Biostatistics Group
18/03/2018 -
A postdoctoral opportunity is available immediately within the Group to work on an integrated approach to combine self-reported and biomarker estimates of dietary exposure, with the aim of exploring the misclassification inherent in these measurements.
Deadline: 31 March 2018

Read more
IARC Internal Seminar: 11th Richard Doll Lecture: Opium as a carcinogen: new insights from the Golestan Cohort Study
15/01/2018 -
11th Richard Doll Lecture
Title: Opium as a carcinogen: new insights from the Golestan Cohort Study
Speaker: Professor Reza Malekzadeh, Director, Digestive Disease Research Center, Tehran University of Medical Sciences, Iran

Watch video
Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice
12/01/2018 -
Cutaneous beta human papillomavirus (HPV) types are suspected to be involved, together with ultraviolet (UV) radiation, in the development of non-melanoma skin cancer, the most common form of human cancer. A new study by researchers from the International Agency for Research on Cancer (IARC) and the German Cancer Research Center (DKFZ), published today in PLoS Pathogens, used a transgenic mouse model in which the expression of beta HPV38 oncogenes can be modulated in the skin. Their findings support the concept that beta HPV types act only at an initial stage of carcinogenesis, by potentiating the deleterious effects of UV radiation.

Viarisio D, Müller-Decker K, Accardi R, Robitaille A, Dürst M, Beer K, et al.
Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice
PLoS Pathog, Published online 11 January 2018
http://dx.doi.org/10.1371/journal.ppat.1006783

Read article , Read more
IARC Monographs Volume 113: DDT, Lindane, and 2,4-D
09/01/2018 -
The International Agency for Research on Cancer (IARC) is pleased to announce that the IARC Monographs volume on the insecticides dichlorodiphenyltrichloroethane (DDT) and gamma-hexachlorocyclohexane (lindane) and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) is now available online.

Visit the Volume 113 webpage
IARC Postdoctoral Opportunities – Section of Nutrition and Metabolism/Nutritional Methodology and Biostatistics Group
03/01/2018 -
A postdoctoral opportunity is immediately available within the Nutritional Methodology and Biostatistics Group to work on the identification of aetiological factors in the occurrence of multi-morbidity and cancer comorbidity. The postdoctoral scientist will join an innovative and scientifically stimulating environment and will have opportunities to interact and collaborate with colleagues from IARC and its networks.

Read more